Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Marshall R. Posner, MD
Dana-Farber Cancer Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Yale-New Haven Hospital
New Haven, Connecticut, United States
- Hematology/oncology Associates
Port Saint Lucie, Florida, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- Cape Cod Health Care
Hyannis, Massachusetts, United States
- Nantucket Cottage Hospital
Nantucket, Massachusetts, United States
- Washington University Barnard Cancer Center
St Louis, Missouri, United States
- Lourdes Regional Cancer Center
Binghamton, New York, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- University of Texas - Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 1999
- Primary completion
- 30 Sept 2001
- Completion
- 30 Sept 2001
- Last update posted
- 18 Apr 2017
- Registered enrollment
- 14
- Registry id
- NCT00004163
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.